Answer
Normosang (human hemin) risks during pregnancy are undefined because specific experimental and clinical data are lacking; although no after-effects have been observed in newborns of treated mothers to date, use is not recommended unless clearly necessary.
Sources for this answer
- Normosang 25 mg/ml, concentrate for solution for infusionRecordati Rare Diseases UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked